Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity



Abstract Views
683

Downloads
475

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Dec 13, 2021
Published Mar 17, 2022
10.24018/ejmed.2022.4.2.1173

Abstract viewed = 683 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

The seroprevalence in Indian states Haryana and Odisha has been investigated. The seropositivity in the Haryana population increased with time from 8% to 14.8% to 76.3% as recorded in August, October 2020, and September 2021, respectively. The virus spread was continuous as the increase in seroprevalence was monotonous. The three COVID-19 pandemic waves that hit Haryana in September, November 2020, and May 2021 infected the population and generated antibodies. The last serosurvey conducted in September 2021 which registered 76.3% seroprevalence might have a contribution from vaccination as 25% of all the population was fully vaccinated and 60% had one dose. The seroprevalence in Odisha was found to be 20.8%, 68.1%, and 73% in the surveys conducted in August 2020, June, and August 2021, respectively. The survey conducted in Odisha in August 2021 found that 93% of the healthcare workers had antibodies suggested that in the general population also, 93% seroprevalence might be possible by strong vaccination drive or repeated virus exposure. A maximum seroprevalence of 75% was found in the age group of 19-44 years and the lowest of 66% was recorded among 60-plus individuals.

Keywords: Antibodies enhancement, Haryana serosurvey, hybrid immunity, Odisha serosurvey

Downloads

Download data is not yet available.

References

  1. The Indian Express. Two years of Covid-19 pandemic: Vaccines, pills, and a mutant in perspective. [Internet] [cited December 3, 2021].
     Google Scholar
  2. The Japan Times. What's behind the rapid disappearance of the delta variant in Japan? It could be self-extinction. [Internet] [cited November 18, 2021].
     Google Scholar
  3. The Japan Times. COVID-19 tracker: Japan logs 50 new cases for year's lowest daily total. [Internet] [cited November 22, 2021].
     Google Scholar
  4. Coronavirus (COVID-19) - Google News. [Internet].
     Google Scholar
  5. The Japan Times. Japan to take mix-and-match approach to COVID-19 booster shots. [Internet] [cited November 17, 2021].
     Google Scholar
  6. The Japan Times. Japan's COVID-19 booster shot drive kicks off with health care workers. [Internet] [cited December 1, 2021].
     Google Scholar
  7. The Asian Age. Active COVID-19 cases in country decline to 98,416, lowest in 552 days. [Internet] [cited December 6, 2021].
     Google Scholar
  8. The Asian Age. Top scientists for COVID booster vaccine dose. [Internet] [cited December 3, 2021].
     Google Scholar
  9. Hindustan Times. Canada health body recommends Covid booster shots for all adults. [Internet] [cited, December 3, 2021].
     Google Scholar
  10. The Japan Times. Get a booster now and don’t wait for an omicron shot, experts say. [Internet] [cited December 3, 2021].
     Google Scholar
  11. The Japan Times. Six vaccines show promise as boosters, led by mRNA shots. [internet] [cited December 3, 2021].
     Google Scholar
  12. Shervani Z, Bhardwaj D, Nikhat R. Dharavi Slums (Mumbai, India): The Petri Dish of COVID-19 Herd Immunity. European Journal of Medical and Health Sciences. 2021; 3(3): 38-41.
    DOI  |   Google Scholar
  13. Shervani Z. COVID-19 in Kerala: Health Index Theory. European Journal of Medical and Health Sciences. 2021; 3(2): 21-24.
    DOI  |   Google Scholar
  14. Shervani Z. COVID-19 in Kerala: The Dynamics of Spread and Health Index Theory. RAS Medical Science. 2021;1(2): 1-3.
    DOI  |   Google Scholar
  15. Shervani Z, Khan I, Siddiqui NY, Khan T, Qazi UY. Viability of SARS-CoV-2 and Sanitization Methods. European Journal of Medical and Health Sciences. 2021; 3(1): 22-27.
    DOI  |   Google Scholar
  16. Z. Shervani, I. Khan, N. Y. Siddiqui, T. Khan and U. Y. Qazi, Risk of SARS-CoV-2 Transmission from Humans to Pets and Vice Versa. European Journal of Medical and Health Sciences. 2021;3(1): 34-38.
    DOI  |   Google Scholar
  17. Shervani Z, Khan I, Qazi UY. SARS-CoV-2 delayed Tokyo 2020 Olympics: Very recent advances in covid-19 detection, treatment, and vaccine development useful conducting the games in 2021. Advances in Infectious Diseases. 2020; 10(3): 56-66.
    DOI  |   Google Scholar
  18. Shervani Z, Khan I, Qazi UY. COVID-19 vaccine. Advances in Infectious Diseases. 2020; 10(3): 195-210.
    DOI  |   Google Scholar
  19. Shervani Z, Khan I, Khan T, Qazi UY. World’s fastest supercomputer picks COVID-19 drug. Advances in Infectious Diseases. 2020; 10(3): 211-225.
    DOI  |   Google Scholar
  20. Shervani Z, Bhardwaj D, Sherwani A, Khan I, Qazi UY. COVID-19 infection in 8 big cities of India: The Dynamics of the Spread and Seropositivity. European Journal of Medical and Health Sciences. 2021; 3(6): 1-5.
    DOI  |   Google Scholar
  21. Shervani Z, Bhardwaj D, Nikhat R. COVID-19 infection in India: Seropositivity versus the Dynamics of the Spread. European Journal of Medical and Health Sciences. 2021; 3(4): 95-99.
    DOI  |   Google Scholar
  22. The Times of India. Antibodies against Covid-19 found in 76.3% people in Haryana, says Anil Vij. [Internet] [cited October 18, 2021].
     Google Scholar
  23. The Indian Express. Three of every four persons in Haryana has Covid antibodies. [Internet] [cited October 19, 2021].
     Google Scholar
  24. Coronavirus: At least 73% of Odisha’s population has antibodies, shows sero survey. [Internet] [cited, September 27, 2021] Available from: scroll.in.
     Google Scholar
  25. % population of Odisha has antibodies against Covid: ICMR survey. [internet] [cited September 27, 2021] Business Standard, Available from: business-stadard.com.
     Google Scholar
  26. Kshatri JS, Bhattacharya D, Kanungo S, Giri S, Palo SK, Parai D, et al. Serological surveys to inform SARS‑CoV‑2 epidemic curve: a cross‑sectional study from Odisha, India, Scientific Reports. 2021; 11: 10551.
    DOI  |   Google Scholar
  27. Hindustan Times. Over 85% healthcare workers in 3 Odisha districts developed Covid-19 antibodies. [Internet] [cited July 24, 2021].
     Google Scholar


Most read articles by the same author(s)

1 2 > >>